Measurement of Serum Calprotectin in Stable Patients Predicts Exacerbation and Lung Function Decline in Cystic Fibrosis

Philip A. Reid*, David A. McAllister, A. Christopher Boyd, J. Alastair Innes, David Porteous, Andrew P. Greening, Robert D. Gray

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)233-236
Number of pages4
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume191
Issue number2
DOIs
Publication statusPublished - 15 Jan 2015

Keywords

  • PULMONARY EXACERBATION
  • BIOMARKERS
  • DISEASE

Cite this